The Role of Integrated Tech in Advancing Clinical Trials
TCS’s white paper emphasizes how a unified, domain-led technology approach—blending real-time data, AI/ML, IoT, and rich domain expertise—can transform clinical development. Key takeaways include:
- Streamlined workflows: Centralizes data, reduces redundancy, standardizes metadata, and cuts overall cycle times by 25–40%, while boosting site efficiency by 40–50%.
- Enhanced patient engagement: Supports decentralized trials with eConsent, eCOA/ePRO, wearable sensors, telemedicine, and proactive reminders—making participation more convenient and compliant.
- Proactive risk oversight: Enables real-time, risk-based monitoring and automated issue detection, pivoting teams from manual operations to intelligent, preventive actions.
- Accelerated decision-making: Near-real-time data integration and AI-driven insights empower early treatment decisions and faster drug approvals.
- Regulatory readiness: Facilitates compliant submissions through streamlined documentation (e.g., eCTD) and ensures audit-ready archives.
By adopting this integrated tech stack—spanning unified platforms to patient- and data-centric solutions—organisations can speed trial execution, improve data quality, reduce costs, and support faster market access for new therapies.
Ready to accelerate your clinical development journey? Explore how TCS’s Unified Technology Solution can transform trials with smarter data, tighter compliance, and stronger patient engagement—reach out to download the full white paper today.
If your Download does not start Automatically, Click Download Whitepaper